Fresh blog: STRATIFY trial for PE
Peripheral tPA infusion is EQUALLY EFFECTIVE as compared to ultrasound-assisted thrombolysis
Catheter-directed thrombolysis for PE is dead
We can get the same benefits with peripheral tPA infusions (w/o procedural costs & complications)... #1/2 #EMIMCC
Up to a third of older people who fall are taking prescribed anticoagulants at the time of the incident.
This article provides guidance on imaging decisions and anticoagulation management in suspected and confirmed traumatic brain injury
www.bmj.com/content/389/...
What are the barriers to recruitment and participation in RCTs evaluating postpartum thromboprophylaxis? This qualitative study reveals trust in providers, altruism, and risk perception as key motivators and barriers. Important insights for future trial design.
www.jthjournal.org/article/S153...
🩸 We're supporting #NHSBloodDonation this #NationalBloodWeek.
A million regular donors are needed to meet demand and help patients in need. If you're the giving type, make it count by becoming a lifesaving blood donor.
Find out more ➡️ bit.ly/3RxPf8N
#NationalBloodWeek25 #GiveBlood
New review discusses underutilization of effective agents for hematologic care.
The team, including @heme-fan.bsky.social and @gbarnesmd.bsky.social recommend addressing this knowledge gap with better patient education resources!
www.rpthjournal.org/article/S247...
@emanhassan.bsky.social
Congratulations!
📢 New in Lancet Haematology!
Our commentary explores how machine learning can personalise blood donation by predicting ferritin recovery—not just haemoglobin. Towards safer, iron-aware donation practices.
doi.org/10.1016/S235...
#Haematology #BloodDonation #DigitalHealth
Have you had a blood clot and would like to get involved with research? Take a look at our news update - lots of opportunities seeking your voice conta.cc/4dLqMa2
Interested in pregnancy-associated VTE? Do you use the RCOG GTG 37a? Here's a commentary @bjog.bsky.social from the guideline update committee. doi.org/10.1111/1471... @isth.org @bhwords.bsky.social @profmakris.bsky.social @middeldorps.bsky.social @fniainle.bsky.social @laranroberts1.bsky.social
👥 Meet the future of thrombosis and hemostasis research. In "Leading from the Start", we highlight the pivotal role of the ISTH SSC and its Early Career Co-Chairs—emerging leaders who are already making a global impact.
Read more here: bit.ly/3XOmNCI
Congratulations to the 2025 Editor’s Awards Recipients! We invite the community to read and share their important contributions ⬇️
Prof. @isabellemahe.bsky.social presents API-CAT at @accintouch.bsky.social published in @nejm.org: Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in cancer patients
www.nejm.org/doi/full/10....
Countries that have issued a travel advisory this year warning their citizens about visiting the United States:
Canada
Denmark
Finland
France
Germany
Ireland
Netherlands
New Zealand
United Kingdom
📢 @jthjournal.bsky.social is proud to announce the recipients of the 2025 JTH Editors’ Awards!
These prestigious awards honor six outstanding early career investigators for their top articles in thrombosis and hemostasis. Join us in congratulating the winners🎉 and learn more here: bit.ly/4lc2pFR
If you are interested in vascular liver diseases , you are definitively interested in joining this COST Action!
Brexit a key factor in worst UK medicine shortages in four years, report says
www.theguardian.com/society/2025...
Very sad. So many good doctors driven to either leaving the NHS or taking their own lives.
The Repeat Study addressed a really important knowledge gap!
The incidence of recurrent events following an ante- or postpartum VTE is 2.4% person-years. The cumulative risks are 6%, 13%, 17%, and 30% at 2, 5, 10, and 30 years respectively
www.jthjournal.org/article/S153...
@jthjournal.bsky.social
Pubmed
I can still access Pubmed - seems to be strange regional variation.
Just picked this up from the library. I am really looking forward to reading now!
Read this State of The Art review on transfusion therapy in trauma first presented at the @isth.org 2024 Congress:
Transfusion in trauma: empiric or guided therapy?
Full paper here: www.rpthjournal.org/article/S2475-0379(24)00358-3/fulltext
As promised, here are the slides I shared with students to convince them to NOT use chatGPT and other artificial stupidity.
TL;DR? AI is evil, unsustainable and stupid, and I'd much rather they use their own brains, make their own mistakes, and actually learn something. 🪄
Large international multicenter cohort study showing that DOACs are a good option to treat cerebral venous thrombosis. Kudos to @jonathancoutinho20.bsky.social and team for pulling this off!
authors.elsevier.com/c/1ke765FFzL...
@nytimes.com positions let go
Did you know? Around 50% of patients with acute CAT in your practice do not meet the inclusion criteria of the RCTs. Listen to the podcast with @gbarnesmd.bsky.social about recent trials taking a more pragmatic approach.
www.medthority.com/medical-educ...
If you're looking for #PsychologicalSafety in academia, this is how it's done- 👏👏👏 to Bond University medical program for recognising effort as much as achievement with awards like the 'Sorry, Try Again Award'. 11 rejections, woohoo! 🤣❤️
Introducing JTH’s new Educational Review Series—your go-to resource for fundamental insights into critical topics in thrombosis and hemostasis ⬇️
